24/7 Market News – (NASDAQ:ENDP) ENDO INTERNATIONAL PLC, shares are moving up nicely this morning more than 9% on 27,000 trades as the company announces to commercialize phase 3 of it’s orthopedic product.


Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Treatment of Osteoarthritis Knee Pain

https://www.prnewswire.com/news-releases/endo-executes-agreement-with-tlc-to-commercialize-phase-3-orthopedic-product-for-the-treatment-of-osteoarthritis-knee-pain-301566308.html

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist